These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 19282418

  • 1. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S, Adel N, Jurcic J.
    J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of vincristine toxicity with concomitant fluconazole prophylaxis in children with acute lymphoblastic leukemia.
    Teusink AC, Ragucci D, Shatat IF, Kalpatthi R.
    Pediatr Hematol Oncol; 2012 Feb; 29(1):62-7. PubMed ID: 22304011
    [Abstract] [Full Text] [Related]

  • 3. Effect of azole antifungal therapy on vincristine toxicity in childhood acute lymphoblastic leukaemia.
    van Schie RM, Brüggemann RJ, Hoogerbrugge PM, te Loo DM.
    J Antimicrob Chemother; 2011 Aug; 66(8):1853-6. PubMed ID: 21652620
    [Abstract] [Full Text] [Related]

  • 4. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ.
    BMC Infect Dis; 2007 Jul 02; 7():70. PubMed ID: 17605773
    [Abstract] [Full Text] [Related]

  • 5. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S, Swaroop C, Thulkar S, Vishnubhatla S, Kabra SK, Xess I, Bakhshi S.
    J Pediatr Hematol Oncol; 2011 Dec 02; 33(8):e333-41. PubMed ID: 22042283
    [Abstract] [Full Text] [Related]

  • 6. Itraconazole-enhanced vincristine neurotoxicity in a child with acute lymphoblastic leukemia.
    Jeng MR, Feusner J.
    Pediatr Hematol Oncol; 2001 Mar 02; 18(2):137-42. PubMed ID: 11255732
    [Abstract] [Full Text] [Related]

  • 7. Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy.
    Heng SC, Slavin MA, Al-Badriyeh D, Kirsa S, Seymour JF, Grigg A, Thursky K, Bajel A, Nation RL, Kong DC.
    J Antimicrob Chemother; 2013 Jul 02; 68(7):1669-78. PubMed ID: 23485723
    [Abstract] [Full Text] [Related]

  • 8. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
    Yu DT, Peterson JF, Seger DL, Gerth WC, Bates DW.
    Pharmacoepidemiol Drug Saf; 2005 Nov 02; 14(11):755-67. PubMed ID: 15654717
    [Abstract] [Full Text] [Related]

  • 9. Management of drug and food interactions with azole antifungal agents in transplant recipients.
    Dodds-Ashley E.
    Pharmacotherapy; 2010 Aug 02; 30(8):842-54. PubMed ID: 20653361
    [Abstract] [Full Text] [Related]

  • 10. Phase II study of sphingosomal vincristine in patients with recurrent or refractory adult acute lymphocytic leukemia.
    Thomas DA, Sarris AH, Cortes J, Faderl S, O'Brien S, Giles FJ, Garcia-Manero G, Rodriguez MA, Cabanillas F, Kantarjian H.
    Cancer; 2006 Jan 01; 106(1):120-7. PubMed ID: 16331634
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F, Baccarani U, Tavio M, Cojutti P, Adani GL, Londero A, Baraldo M, Franceschi L, Furlanut M, Viale P.
    Ann Pharmacother; 2008 Nov 01; 42(11):1711-6. PubMed ID: 18812562
    [Abstract] [Full Text] [Related]

  • 12. Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
    Marty FM, Lowry CM, Cutler CS, Campbell BJ, Fiumara K, Baden LR, Antin JH.
    Biol Blood Marrow Transplant; 2006 May 01; 12(5):552-9. PubMed ID: 16635790
    [Abstract] [Full Text] [Related]

  • 13. A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML).
    Vehreschild JJ, Böhme A, Buchheidt D, Arenz D, Harnischmacher U, Heussel CP, Ullmann AJ, Mousset S, Hummel M, Frommolt P, Wassmer G, Drzisga I, Cornely OA.
    J Infect; 2007 Nov 01; 55(5):445-9. PubMed ID: 17822770
    [Abstract] [Full Text] [Related]

  • 14. Clinical Analysis of Adverse Drug Reactions between Vincristine and Triazoles in Children with Acute Lymphoblastic Leukemia.
    Yang L, Yu L, Chen X, Hu Y, Wang B.
    Med Sci Monit; 2015 Jun 07; 21():1656-61. PubMed ID: 26050202
    [Abstract] [Full Text] [Related]

  • 15. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
    Jain S, Kapoor G.
    Pediatr Blood Cancer; 2010 May 07; 54(5):783. PubMed ID: 20205256
    [No Abstract] [Full Text] [Related]

  • 16. Dexamethasone-associated toxicity during induction chemotherapy for childhood acute lymphoblastic leukemia is augmented by concurrent use of daunomycin.
    Belgaumi AF, Al-Bakrah M, Al-Mahr M, Al-Jefri A, Al-Musa A, Saleh M, Salim MF, Osman M, Osman L, El-Solh H.
    Cancer; 2003 Jun 01; 97(11):2898-903. PubMed ID: 12767105
    [Abstract] [Full Text] [Related]

  • 17. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
    Mokhtar GM, Shaaban SY, Elbarbary NS, Fayed WA.
    J Pediatr Hematol Oncol; 2010 Nov 01; 32(8):594-600. PubMed ID: 20921909
    [Abstract] [Full Text] [Related]

  • 18. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N, DePestel DD, Mackler ER, Collins CD, Welch K, Erba HP.
    Pharmacotherapy; 2007 Jul 01; 27(7):970-9. PubMed ID: 17594202
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic drug interactions of vinca alkaloids: summary of case reports.
    Chan JD.
    Pharmacotherapy; 1998 Jul 01; 18(6):1304-7. PubMed ID: 9855331
    [Abstract] [Full Text] [Related]

  • 20. The role of voriconazole in the treatment of central nervous system blastomycosis.
    Ta M, Flowers SA, Rogers PD.
    Ann Pharmacother; 2009 Oct 01; 43(10):1696-700. PubMed ID: 19724015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.